Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeroen P Jansen

Showing results (1-10 of 112) with videos related to

Pageof 12
Sort By:
Current Medical Research and Opinion|May 11, 2006
Self-monitoring of glucose in type 2 diabetes mellitus: a Bayesian meta-analysis of direct and indirect comparisonsJeroen P Jansen
BMC Medical Research Methodology|May 10, 2011
Network meta-analysis of survival data with fractional polynomialsJeroen P Jansen
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 7, 2017
Relevance of American Society of Clinical Oncology Value Framework Will Be Improved if It Is Based on Network Meta-AnalysesJeroen P Jansen
Research Synthesis Methods|June 11, 2015
Network meta-analysis of individual and aggregate level dataJeroen P Jansen
BMC Medicine|July 6, 2013
Is network meta-analysis as valid as standard pairwise meta-analysis? It all depends on the distribution of effect modifiersJeroen P Jansen, Huseyin Naci
BMC Medical Research Methodology|December 3, 2013
Quantitative summaries of treatment effect estimates obtained with network meta-analysis of survival curves to inform decision-makingShannon Cope, Jeroen P Jansen
BMC Medical Research Methodology|October 10, 2012
Meta-regression models to address heterogeneity and inconsistency in network meta-analysis of survival outcomesJeroen P Jansen, Shannon Cope
International Journal of Rheumatology|July 21, 2011
Cost-Effectiveness Evaluation of Etoricoxib versus Celecoxib and Nonselective NSAIDs in the Treatment of Ankylosing Spondylitis in NorwayJeroen P Jansen, Stephanie D Taylor
Pharmacoeconomics|November 14, 2009
Accounting for the development of antibacterial resistance in the cost effectiveness of ertapenem versus piperacillin/tazobactam in the treatment of diabetic foot infections in the UKJeroen P Jansen, Ritesh Kumar, Yehuda Carmeli
AIDS Research and Human Retroviruses|September 10, 2011
Epidemiology of HIV-related neuropathy: a systematic literature reviewSabyasachi Ghosh, Arthi Chandran, Jeroen P Jansen
Pageof 12

Showing results (1-10 of 112) with videos related to

Sort By:
Pageof 12
Current Medical Research and Opinion|May 11, 2006
Self-monitoring of glucose in type 2 diabetes mellitus: a Bayesian meta-analysis of direct and indirect comparisonsJeroen P Jansen
BMC Medical Research Methodology|May 10, 2011
Network meta-analysis of survival data with fractional polynomialsJeroen P Jansen
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 7, 2017
Relevance of American Society of Clinical Oncology Value Framework Will Be Improved if It Is Based on Network Meta-AnalysesJeroen P Jansen
Research Synthesis Methods|June 11, 2015
Network meta-analysis of individual and aggregate level dataJeroen P Jansen
BMC Medicine|July 6, 2013
Is network meta-analysis as valid as standard pairwise meta-analysis? It all depends on the distribution of effect modifiersJeroen P Jansen, Huseyin Naci
BMC Medical Research Methodology|December 3, 2013
Quantitative summaries of treatment effect estimates obtained with network meta-analysis of survival curves to inform decision-makingShannon Cope, Jeroen P Jansen
BMC Medical Research Methodology|October 10, 2012
Meta-regression models to address heterogeneity and inconsistency in network meta-analysis of survival outcomesJeroen P Jansen, Shannon Cope
International Journal of Rheumatology|July 21, 2011
Cost-Effectiveness Evaluation of Etoricoxib versus Celecoxib and Nonselective NSAIDs in the Treatment of Ankylosing Spondylitis in NorwayJeroen P Jansen, Stephanie D Taylor
Pharmacoeconomics|November 14, 2009
Accounting for the development of antibacterial resistance in the cost effectiveness of ertapenem versus piperacillin/tazobactam in the treatment of diabetic foot infections in the UKJeroen P Jansen, Ritesh Kumar, Yehuda Carmeli
AIDS Research and Human Retroviruses|September 10, 2011
Epidemiology of HIV-related neuropathy: a systematic literature reviewSabyasachi Ghosh, Arthi Chandran, Jeroen P Jansen
Pageof 12